>>If they could bring back the genomics bubble circa 1999-2000, wouldn’t that do the trick? :- )<<
Since they haven't done anything with genomics for at least 6 years ... no. Apparently Friedman didn't even get any of his drug targets from Incyte's old database. I think they even let most of their 'gene patents' lapse, though I'm not 100% sure about that.
Market Data 
Markets 
AI
